Summit Therapeutics SMMT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating lease liabilities (current)?
- Summit Therapeutics (SMMT) reported operating lease liabilities (current) of $3.18M in Q1 2026.
- How has Summit Therapeutics's operating lease liabilities (current) changed year-over-year?
- Summit Therapeutics's operating lease liabilities (current) decreased by 10.3% year-over-year, from $3.54M to $3.18M.
- What is the long-term trend for Summit Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease liabilities (current) has grown at a 54.1% compound annual growth rate (CAGR), from $390K to $3.39M.
- What does operating lease liabilities (current) mean?
- The portion of lease payments due within one year.
- How do you interpret operating lease liabilities (current)?
- An increase reflects expanding physical footprint or higher rental costs, while a decrease indicates lease expirations or reduced facility requirements.
- How does operating lease liabilities (current) compare across companies?
- Standardized under ASC 842; comparable across all companies with significant real estate or equipment leases.